Description
Premium research-grade CJC-1295 & Ipamorelin blend supplied as a lyophilized compound for laboratory research use by qualified professionals. Manufactured under controlled conditions to ensure purity, stability, and analytical consistency.
For laboratory research use only. Not for human or animal use.
Detailed Compound Composition
Two available blends provide a precise mix of the following peptide components:
5/5 mg Blend (10 mg)
- CJC-1295 (without DAC): 5 mg
- Ipamorelin: 5 mg
10/10 mg Blend (20 mg)
- CJC-1295 (without DAC): 10 mg
- Ipamorelin: 10 mg
Technical Classification
- Classification: Combination of a growth hormone–releasing hormone (GHRH) analog and a growth hormone secretagogue peptide
- Source: Synthetic (laboratory-produced)
- Physical Form: Lyophilized powder
- Purity: >99% (HPLC)
Research Context
This peptide blend is utilized in experimental research exploring growth hormone axis signaling and pulsatile growth hormone secretion dynamics in preclinical studies.
- Growth hormone–releasing hormone receptor signaling pathways
- Growth hormone secretagogue receptor (GHS-R) activity
- Pulsatile GH secretion pattern analysis
- Endocrine signaling and feedback regulation models
- Peptide synergy in hormonal axis research
Studies are limited strictly to in vitro and preclinical models for mechanistic and pathway-level investigation, not therapeutic use.
Handling & Storage
- Storage Conditions: 2–8 °C, protected from light
- Stability: Lyophilized format supports extended stability when stored under recommended conditions
- Reconstitution: For laboratory research protocols only, using appropriate sterile laboratory techniques
